SOTACPharmaceuticals
Sotac Pharmaceuticals Ltd — PE Ratio & Valuation Analysis
₹109.25
+0.00%
Current P/E17.88xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E36.6x51.2% below avg
✅
43.7% Discount to Industry
SOTAC P/E 17.88x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹3.90 | ₹109 | 28x |
| 2023 | ₹2.61 | ₹118 | 45.3x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Sotac Pharmaceuticals Ltd Valuation
Sotac Pharmaceuticals Ltd (SOTAC) currently trades at 17.88x earnings. The Pharmaceuticals sector average PE is 31.77x. SOTAC is trading at a discount to peers — may indicate relative value. Historically, SOTAC has traded at an average PE of 36.6x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
15.71%
Dividend Yield
0.07%
More on Sotac Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.